신경혈관용 마이크로카테터 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Neurovascular Microcatheter Market Summary

The global neurovascular microcatheter market size was valued at USD 703.98 million in 2025 and is projected to reach USD 1,224.73 million by 2033, growing at a CAGR of 7.07% from 2026 to 2033. The industry is driven by the rising prevalence of neurovascular aneurysms, which is increasing demand for minimally invasive procedures such as coiling and flow diversion, where precise catheter navigation is essential.

In addition, the growing incidence of ischemic stroke is a major factor, as these devices are widely used in mechanical thrombectomy procedures to restore blood flow quickly and effectively. The expanding global burden of stroke, particularly among aging populations, further supports market growth. Moreover, the rising cases of hypertension, a key risk factor for both aneurysms and strokes, are contributing to a larger patient pool requiring neurovascular interventions, thereby boosting the demand for advanced microcatheter technologies and supporting overall market expansion globally.

The rising prevalence of neurovascular aneurysms is growing the market for neurovascular microcatheters, as it significantly increases the demand for minimally invasive treatment procedures. Cerebral aneurysms, if left untreated, can rupture and lead to severe complications such as hemorrhagic stroke, prompting early diagnosis and timely intervention. This has led to an increasing number of endovascular procedures, including coil embolization and flow diversion, where microcatheters are essential for precise navigation through complex cerebral vessels. According to the Hereditary Brain Aneurysm Support 2025, unruptured brain aneurysms, localized bulges or swellings in the brain's blood vessels, are relatively common, affecting about 3% of the UK population, or roughly 2 million people. While most aneurysms remain asymptomatic and do not cause problems, a small number, between 3,000 and 5,000 cases each year, rupture, with approximately half of these resulting in fatal outcomes. In addition, advancements in imaging technologies and increasing awareness among patients and healthcare providers have improved early detection rates. The shift toward minimally invasive techniques, due to reduced recovery time and lower procedural risks, is further accelerating adoption.

"Brain aneurysms typically produce no symptoms but can burst without warning with catastrophic consequences. The reality is that most brain aneurysms will never rupture, but we currently have no way of identifying the minority that will. We are making great strides in understanding clinical risk factors but our ability to understand the genetics behind their development and understand why they rupture remains surprisingly limited for a condition that potentially impacts 3% of the UK population."- Professor Diederik Bulters, Consultant Neurosurgeon at UHS, Honorary Professor of Neurovascular Surgery at the University of Southampton, and Chief Investigator of the ROAR Study.

The rising prevalence of stroke is growing the market for neurovascular microcatheters, as it significantly increases the need for timely and effective treatment interventions. Ischemic strokes, which account for the majority of cases, require procedures such as mechanical thrombectomy to restore blood flow to the brain quickly. Neurovascular microcatheters play a vital role in these procedures by enabling precise navigation through complex cerebral arteries and supporting accurate device delivery. The increasing incidence of stroke, driven by aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity, is leading to a higher number of interventional procedures. In addition, growing awareness about early stroke management and improved healthcare infrastructure are further boosting the adoption of neurovascular microcatheters, thereby driving market growth.

Technological advancements are driving the neurovascular microcatheter market by significantly improving the performance, safety, and precision of endovascular procedures. Innovations such as enhanced flexibility, smaller diameters, improved trackability, and hydrophilic coatings enable microcatheters to navigate complex, tortuous cerebral vessels with greater ease and accuracy. In 2025, Researchers at EPFL developed an extremely small, highly flexible neurovascular microcatheter that can navigate complex, branching blood vessels with ease. Uniquely, the device is driven by natural blood flow, allowing it to travel quickly and safely through intricate arterial pathways, improving navigation and reducing the risk during neurovascular procedures.

"Catheters eliminate concerns about device removal after use, and don't have limited payloads. At the same time, many blood vessels lie beyond a traditional catheter's reach," Sakar explains. "That's why we have developed and tested MagFlow: an ultraminiaturized magnetic microcatheter - twice as small as benchmark microcatheters - that minimizes contact with vessel walls by hitching a ride on the blood stream's own kinetic energy." - head of the MicroBioRobotic Systems Laboratory in EPFL's School of Engineering

The development of dual-lumen, steerable microcatheters further enables better control and targeted delivery of therapeutic devices during procedures such as coil embolization and thrombectomy. In addition, integration with advanced imaging systems and real-time navigation technologies enhances procedural outcomes and reduces risks. These continuous improvements are increasing physician confidence, expanding the scope of minimally invasive treatments, and driving the adoption of neurovascular microcatheters across healthcare settings.

Global Neurovascular Microcatheter Market Report Segmentation

This report forecasts global, regional, and country-level revenue growth and analyzes the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurovascular microcatheter market report on the basis of type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Single-Lumen Microcatheters
• Dual-Lumen Balloon Microcatheters
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Diagnostic Delivery
• Therapeutic Embolization Delivery
• Temporary Occlusion / Flow Control
• Vascular Access & Navigation
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Neurovascular Microcatheter Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of neurovascular diseases
    • 3.2.1.2. Increasing adoption of minimally invasive neurovascular procedures
    • 3.2.1.3. Technological advancements in microcatheters
    • 3.2.1.4. Expansion of neurointerventional infrastructure and catheterization laboratories
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of neurovascular procedures and devices
    • 3.2.2.2. Stringent regulatory approval processes for neurovascular devices
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Increasing adoption of outpatient and ambulatory surgical centers
    • 3.2.3.2. Growing demand in emerging markets s
    • 3.2.3.3. Rising research and development investments in neurovascular devices
    • 3.2.3.4. Increasing awareness and early diagnosis of neurological disorders
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Complexity of neurovascular procedures
    • 3.2.4.2. High training requirements for physicians
• 3.3. Neurovascular Microcatheter Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Microcatheter Market: Type (Capacity / Model-Based) Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Neurovascular Microcatheter Market: Type Movement Analysis
• 4.3. Neurovascular Microcatheter Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Single-Lumen Microcatheters
  • 4.5.1. Single-Lumen Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Dual-Lumen Balloon Microcatheters
  • 4.6.1. Dual-Lumen Balloon Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Microcatheter Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Neurovascular Microcatheter Market: Application Movement Analysis
• 5.3. Neurovascular Microcatheter Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Diagnostic Delivery
  • 5.5.1. Diagnostic Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Therapeutic Embolization Delivery
  • 5.6.1. Therapeutic Embolization Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Temporary Occlusion / Flow Control
  • 5.7.1. Temporary Occlusion / Flow Control Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Vascular Access & Navigation
  • 5.8.1. Vascular Access & Navigation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Microcatheter Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Neurovascular Microcatheter Market: End Use Movement Analysis
• 6.3. Neurovascular Microcatheter Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Clinics
  • 6.6.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Ambulatory Surgical Centers
  • 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Diagnostic Centers
  • 6.8.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Microcatheter Market: Regional Estimates & Trend Analysis, by Type, by Application, and by End Use

• 7.1. Regional Dashboard
• 7.2. Regional Neurovascular Microcatheter Market Movement Analysis & Market Share, 2025 & 2033
• 7.3. Neurovascular Microcatheter Market: Regional Estimates & Trend Analysis
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Share Analysis, 2025
• 8.3. Key Company Profiles
  • 8.3.1. Stryker
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Medtronic
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. MicroVention (Terumo)
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Balt
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Johnson & Johnson (Cerenovus)
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Penumbra (Boston Scientific Corporation)
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Cook Medical
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Merit Medical
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Asahi Intecc
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Integer Holdings
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Acandis GmbH (Lauxera Capital Partners)
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. phenox GmbH (Wallaby Medical)
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives